Plasma von Willebrand factor antigen concentration as a predictor of von Willebrand's disease status in German Wirehaired Pointers

被引:0
作者
Brooks, M [1 ]
Raymond, S [1 ]
Catalfamo, J [1 ]
机构
[1] NEW YORK STATE DEPT HLTH,WADSWORTH CTR LABS & RES,ALBANY,NY 12201
关键词
canine species; von Willebrand's disease; von Willebrand factor;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To evaluate the use of plasma von Willebrand's factor (vWF) concentration as a screening test for inherited von Willebrand's disease (vWD) in German Wirehaired Pointers (GWHP). Design-Prospective study. Sample Population-Plasma samples from 467 GWHP. Procedure-Plasma VWF concentrations were measured as vWF antigen (vWF:Ag), using ELISA, and test values were used to estimate prevalence of vWD in GWHP and predict parental vWD status. Test results of progeny from matings of carrier and noncarrier parents were then compared with the predicted outcome of such matings. Results-376 (81%) GWHP were classified as vWD noncarriers, 58 (12%) as carriers, and 5 (1%) as affected with vWD. An additional 28 (6%) GWHP could not be classified on the basis of plasma vWF:Ag concentration. The observed outcome of tests of 213 pups was not significantly different from that predicted on the basis of parental vWF:Ag concentration. The predictive value of a positive test result (VWF: Ag% < 50) for identifying vWD carriers was 0.89. Clinical Implications-Plasma vWF:Ag concentration was an effective predictor of genetic status for the vWD trait, and for the outcome of matings between carriers and noncarriers of vWD in this study of GWHP.
引用
收藏
页码:930 / &
页数:5
相关论文
共 50 条
  • [41] Von Willebrand Factor in Health and Disease
    P. P. Avdonin
    N. V. Tsvetaeva
    N. V. Goncharov
    E. Yu. Rybakova
    S. K. Trufanov
    A. A. Tsitrina
    P. V. Avdonin
    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2021, 15 : 201 - 218
  • [42] Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study
    Krahforst, Alexander
    Yadegari, Hamideh
    Pavlova, Anna
    Pezeshkpoor, Behnaz
    Mueller, Jens
    Poetzsch, Bernd
    Scholz, Ute
    Richter, Heinrich
    Trobisch, Heiner
    Liebscher, Karin
    Olivieri, Martin
    Trautmann-Grill, Karolin
    Knoefler, Ralf
    Halimeh, Susan
    Oldenburg, Johannes
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (11) : 3010 - 3034
  • [43] Continuous infusion of human plasma-derived von Willebrand factor concentrate as an effective therapy in a patient with acquired von Willebrand disease
    Patel, S. B.
    Rodgers, G. M.
    HAEMOPHILIA, 2014, 20 (06) : E411 - E414
  • [44] Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance
    Castaman, G.
    Tosetto, A.
    Rodeghiero, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 71 - 74
  • [45] Preclinical evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease
    Schwarz, HP
    Dorner, F
    Mitterer, A
    Mundt, W
    Schlokat, U
    Pichler, L
    Turecek, PL
    WIENER KLINISCHE WOCHENSCHRIFT, 1999, 111 (05) : 181 - 191
  • [46] Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/ factor VIII concentrate
    Iorio, Alfonso
    James, Paula
    Ma, Alice
    Srivastava, Alok
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (10) : 2739 - 2744
  • [47] Sulfatide-binding assay for von Willebrand factor: Detection of von Willebrand's disease without discrimination of vWD subtypes
    Favaloro, EJ
    THROMBOSIS RESEARCH, 2000, 98 (02) : 213 - 219
  • [48] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy
    Delbrueck, Christiane
    Miesbach, Wolfgang
    ACTA HAEMATOLOGICA, 2019, 142 (02) : 71 - 78
  • [49] Von Willebrand factor's clearance
    Denis, Cecile V.
    Lenting, Peter J.
    HEMATOLOGIE, 2006, 12 (01): : 34 - 43
  • [50] Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease
    Roussi, J
    Turecek, PL
    André, P
    Bonneau, M
    Pignaud, G
    Sollier, CBD
    Schlokat, U
    Dorner, F
    Schwarz, HP
    Drouet, L
    BLOOD COAGULATION & FIBRINOLYSIS, 1998, 9 (04) : 361 - 372